N/A
N=1,377
PrEP4Her: Developing a Novel Strategy to Implement PrEP Into Women's Healthcare
PrEP Precriptions for Reproductive Aged Women
Bottom Line
View on ClinicalTrials.gov: NCT07209722 ↗Enrolled (actual)
1,377
Serious AEs
0.0%
Results posted
Jan 2026
Primary outcome: Primary: PrEP Prescriptions — 11; 0 Participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- PrEP acronym (pre-exposure prophylaxis) (Behavioral)
- Age
- Adult · 18+ yrs
- Sex
- Female
- Sponsor
- University of Alabama at Birmingham
- Primary completion
- Aug 2025
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY PrEP Prescriptions |
11; 0 | — |
Summary
The purpose of the study is to learn more about health care providers' experiences and perspectives on prescribing HIV pre-exposure prophylaxis, also known as PrEP. Providers and patients in gynecology clinics were interviewed and completed surveys to measure the feasibility and preference of prescribing PrEP.
Eligibility Criteria
Inclusion Criteria
- Patient of UAB GYN clinic
Exclusion Criteria
- Not a patient of UAB GYN clinic
Data sourced from ClinicalTrials.gov (NCT07209722). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.